Understanding efficacy of current drugs and paving way for new onesOctober 22nd, 2010 - 3:14 pm ICT by ANI
Washington, Oct 22 (ANI): Scientists at the National High Magnetic Field Laboratory and Institute of Molecular Biophysics at Florida State University and researchers at Brigham Young University in Utah are close to understanding why these drugs have become less effective - and how new drugs might take their place.
“Resistance to drugs is a fundamental problem that develops from their misuse, overuse and underuse,” said Timothy A. Cross.
Compounding the problem is that “the development of new drugs to take their place is a decade-long process with infrequent success.”
Two of the four antiviral drugs used to treat a nasty case of the influenza A virus no longer work. The protein, called the M2 channel, plays a key role in the virus’ ability to reproduce. But the M2 channel mutated just enough to allow the virus to resist both drugs.
Detailed MRI scans allowed the researchers to chart the tiniest, previously unknown aspects of the protein’s atomic structure.
“Now that we have a much more refined view of M2 - going all the way down to the atomic level, the level that includes protons going through the channel - we can draw conclusions about how to block it,” said David Busath, a biophysicist at Brigham Young University.
Busath and his team have already begun screening millions of compounds, looking for drugs that will bind to the channel and block its reproductive role.
As to why the longtime flu drugs have become ineffective, the massive misuse of amantadine in poultry may have played a role, Cross said.
“It’s terrible to utilize these miracle drugs that can save thousands, if not millions, of lives and dramatically reduce hospitalizations in that fashion,” Cross said.
The study has been published in the journal Science. (ANI)
- How antiviral drugs block flu virus - Feb 04, 2010
- Biophysicist attempts to block protein to prevent breast, prostate cancer - Apr 20, 2011
- New compound destroys deadly flu virus - Sep 26, 2011
- Drugs checkmating cancer may combat resistant bugs - Dec 23, 2011
- Discovery suggests new way to prevent HIV from infecting human cells - Dec 23, 2010
- Chemical mechanism behind bugs' antibiotic resistance identified - Apr 29, 2011
- Antibiotic-resistant superbugs 'could take us to pre-Penicillin era' - Apr 07, 2011
- Insight into structure of HIV protein may help design drugs - Jun 10, 2010
- Snobbish bugs prefer coffee for beverage - Jun 08, 2011
- Improved, '60,000 times more potent' compound to effectively treat HIV - Jan 26, 2010
- 'Smart' lung cancer drug shows promise - Oct 28, 2010
- Potent new drugs likely from witches' brew - Oct 10, 2011
- Model shows promise to develop therapies for protein folding diseases - Apr 28, 2011
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- Scientists discover key difference in 'kiss of death' sequence of TB bacteria - Oct 18, 2010
Tags: amantadine, antiviral drugs, atomic level, biophysicist, brigham young university, busath, close to understanding, florida state university, flu drugs, fundamental problem, going all the way, influenza a virus, journal science, magnetic field laboratory, miracle drugs, molecular biophysics, nasty case, national high magnetic field, national high magnetic field laboratory, new drugs